I’ve wrestled with how to handle the conflicting, confounding, wide-ranging statistics yielded by these surveys. My solution to this challenge comes tailor-made in this week’s New England Journal of Medicine, dated August 12 2009. The uber-health pollster Bob Blendon of Harvard has done a sort of meta-analysis of the polls and has a fresh take.
His article is titled, “The US Public’s Expectations of Results of Health Care Reform on Various Measures.” Among the measures Blendon focuses on:
Access to health care: about 1 in 2 Americans expect access to expand, while 20% expect access to fall.
Quality of care: 41% believe it will improve, yet 25% forecast quality to fall and 28% expect it to stay the same.
Cost of care: a mixed bag, with the Kaiser Family Foundation poll finding that a plurality of Americans expect costs to fall, while a Gallup poll found a plurality of Americans believe costs will increase. Just how does that happen to fall the way it did, anyway? Inquiring minds want to know!
Taxes: in the Fox poll, most Americans believe they will increase.
Blendon and his co-author John Benson identify three factors that shape Americans’ potential support for health reform: “Will reform improve the nation’s health care system? Will their own care get better? Will their own costs become less burdensome?”
Health Populi’s Hot Points: Blendon and Benson concur (as I do) that the majority of Americans want major change in our health system. However, at the end of the day — that is, when/if health reform gets passed — support on the final plan will depend on, “Americans’ believing that they and the country will be better off if such a change is enacted.”
At the end of the day, that means it’s, first, all about “me” — a very American concept.





Thanks to Jennifer Castenson for
I'm grateful to be part of the Duke Corporate Education faculty, sharing perspectives on the future of health care with health and life science companies. Once again, I'll be brainstorming the future of health care with a cohort of executives working in a global pharmaceutical company.